Home › Medicines › Fluvas
💊

Fluvas

Capsule

🧬 Fluvastatin 🏢 Silva Pharmaceuticals Ltd.
Generic Name Fluvastatin
Manufacturer Silva Pharmaceuticals Ltd.
Unit Price Unit Price: ৳ 12.05 (2 x 6: ৳ 144.60) Strip Price: ৳ 72.30

🔹 Indications

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Pharmacology

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Dosage & Administration

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Interaction

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Contraindications

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Side Effects

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Pregnancy & Lactation

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Precautions & Warnings

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

🔹 Storage Conditions

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to:
  • Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia 
  • Reduce elevated TC, LDL-C, and Apo B levels in boys and post-menarchal girls, 10 to 16 years of age, with heterozygous familial hypercholesterolemia after failing an adequate trial of diet therapy
  • Reduce the risk of undergoing revascularization procedures in patients with clinically evident CHD
  • Slow the progression of atherosclerosis in patients with CHD.

💡 Frequently Asked Questions

Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia  Reduce eleva...
Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia  Reduce eleva...
Fluvas is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce elevated TC, LDL-C, Apo B, and TG, and to increase HDL-C in adult patients with primary hypercholesterolemia and mixed dyslipidemia  Reduce eleva...

User Reviews

⭐
No reviews yet!
Be the first to share your experience.

Write a Review

Alternative Medicines
(Same Generic)

Lesterol Capsule

Opsonin Pharma Ltd.

Unit Price: ৳ 12.05 (1 x 10: ৳ 120.50) Strip Price: ৳ 120.50